Amy Hay is an experienced leader in setting strategy, negotiating transactions and implementing global oncology programs. Her expertise lies within identifying synergistic relationships that provide value and her portfolio has ranged from working with health systems, governments, corporations, providers and industry leaders worldwide.
In April 2021, Siemens Healthineers acquired Varian and Amy has been leading integration teams within the oncology workstream to ensure synergies across both organizations are identified and targets are exceeded in commercial acceleration and platform expansion.
Today Amy is responsible for the strategic initiatives and the deployment of “Oncology as a Service” (OaaS), which aggregates medical technology, clinical solutions and technology enabled services globally. Set by her strategy, Varian has built out technology enabled solutions that span virtual tumor boards and molecular analytics. Within her first year, she closed a partnership with Ayala Health in the Philippines and CHRISTUS Health in the US, providing cumulative revenues of more than $75M.
Amy joined Varian through the acquisition of her consulting company, Evolve International, in January of 2020. Evolve provided strategic consulting to healthcare providers, not-for-profit organizations, health related startups and big data technology companies such as the Eliminate Cancer Initiative in Australia, M2GEN at the Moffitt Cancer Center, City of Hope, Nano and the Cancer Commons.
Logan in the Supply Chain and Procurement Lead for the Buchan Offshore Wind Farm. His role is to deliver the Supply Chain Strategy and Procurement roadmap of the project. Logan is a Chartered Civil Engineering surveyor with ten year experience across various sectors including Water, Wastewater, O&M, Electricity transmission and most recently – Offshore Wind – on project such as Dogger Bank, Inch cape and Morecambe Wind Farm.
Ashley McKelvey, Client Director at 4G Clinical, provides strategic leadership and 13 years of experience in enterprise-level RTSM implementation and account management. She has a deep background successfully collaborating with Top 20 Pharma sponsors, leveraging her expertise across various RTSM platforms from both vendor and client perspectives. Ashley is driven by a passion for understanding and simplifying complex clinical trial implementation challenges while ensuring strategic alignment and growth for her enterprise accounts, building meaningful and collaborative partnerships both internally and externally.
Sallie Quinn is a Client Director at 4G Clinical with over a decade of experience in the RTSM industry. She specializes in client governance, strategic account management, and seamless client onboarding. Sallie’s portfolio spans from emerging biotech organizations to Top 10 global pharmaceutical companies. She is passionate about cultivating strong, lasting client relationships and driving operational excellence and alignment across global clinical trial programs.
Remi is a Chartered Engineer with 24 years of experience working across manufacturing industry, academia and industrial facing research organisations. Within NMIS he is the Head of Strategic Planning, where he ensures NMIS is at the cutting-edge of manufacturing and is able to deliver transformational capabilities to Scotland and the wider UK. He is the Senior Responsible Owner for the NMIS Strategic Wind Programme.
Heewon Lee is a Clinical Research Lead at Eli Lilly, responsible for leading the initiation and operation execution of clinical trials for Lilly molecules. Her work focuses on country feasibility, site selection, and investigator engagement. She has over 12 years of experience in the pharmaceutical industry brings deep expertise in clinical operations.
Constantin Weberpals is a researcher focused on applying artificial intelligence to clinical research and operations. With a background in information systems and machine learning, his work has explored machine-learning-based biomarkers and AI for clinical trial operations at Stanford University. He also worked at McKinsey & Company, advising biopharma on improving operational efficiency through technology.
As part of the Offshore Wind Delivery team at Scottish Enterprise John is responsible for Developer Engagement around ScotWind and INTOG projects. He is also Category Manager for foundations and substructures. In these roles he works with developers, industry and the supply chain to maximise the economic opportunities for Scotland. John has been with Scottish Enterprise since 2006 and has worked in international marketing, international trade and in sector teams covering Energy Systems and Offshore Wind. Prior to this John worked in the private sector in international marketing for software companies.
